Clinical Laboratory Services Market, 8th Edition

Clinical Laboratory Services Market, 8th Edition

Your Resource for Business Planning in the Clinical Laboratory Market

What’s the size of the service market for clinical testing? What type of tests are selling? Where is this market going next five years? Which companies will earn those revenues? Where is growth coming from? How will LDT regulation affect the market? What are companies planning with COVID-19 largely endemic?

These questions and more are answered in Kalorama’s Clinical Laboratory Services report. laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more.

Now in 8 Editions, Kalorama’s Report on the Market Opportunity in Lab Services

Clinical Laboratory Services Market, 8th Edition provides an overview of the clinical laboratory industry and the trends driving growth.

Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies.

The laboratory services market is covered by specialty, including:

• Essential and Routine Testing (Clinical Chemistry, Hematology, Coagulation, Endocrinology)
• Immunology Testing
• Microbiology Testing
• Cytology and Histology Testing (HPV, Tumor Pathology)
• Genetic Testing (Prenatal and Other Genetic)
• Toxicology Testing (Drugs of Abuse)
• COVID-19

The clinical lab test is competitive in hospitals, reference laboratories, and in physician office labs and clinics. This report covers all of these markets. A global market analysis by laboratory type is also displayed, including:

• Independent and Reference Laboratories
• Hospital-based Laboratories
• Clinic-based Laboratories
Clinical lab tests are sold worldwide. Information is presented as a global focused market report, with key regions discussed including:
• North America (United States, Canada)
• Europe, Middle East, and Africa – EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
• Asia Pacific (Japan, China, India, South Korea, Australia)
• Latin America (Brazil, Mexico)

Also included is a competitive analysis of leading clinical laboratory providers.

All market data pertains to the world market at the manufacturers’ level. The base year for data is 2022. Historical data is provided for the years 2017 through 2021, with forecast data provided for 2023 through 2027. Compound annual growth rates (CAGRs) are provided for the 2022-2027 periods for each segment covered. A U.S. competitive analysis is provided for the year 20221. The forecasted market analysis through 2027 was largely based on demographic trends, disease trends, new developments, company performance trends, merger and acquisitions, and national expansion.

Among the scores of tables included in this report the following information is provided:

• Markets and Forecasts for Chemistry Testing Lab Services , 2022-2027
• Markets for Infectious Disease Testing Lab Services, 2022-2027
• Markets for COVID-19 Testing Lab Services, 2022-2027
• Markets for Genetic Testing Lab Services, 2022-2027
• Markets for Prenatal Testing Lab Services, 2022-2027
• Other Lab Services Markets Lab Services , 2022-2027
• Market Share of Top Laboratories
• Market Revenues by Venue
• CLIA Clinical Laboratory Registration by Primary Laboratory Type: April 2023
• Growth in Clinical Laboratories, 2000-2023
• Leading U.S. Independent Laboratory Groups, Distribution of Center
• Growth in U.S. Hospital Laboratory Locations, June 2011 through April 2023
• Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through April 2023
• Global Health Spending as a Percentage of GDP, by Country
• Global Population Trends Age 65+, 2000-2050 (Millions)
• Global Prevalence of Disease, 2000, 2015 and Projected 2030 (Hypertension, Diabetes, Depression, Asthma, CHD, COPD, Epilepsy, Alzheimer’s Disease, HIV/AIDS, Stroke, Cancer, TB, Parkinson’s)
• Medical Doctors per 1,000 Population by Country, 2019/2020
• Global Nursing Establishments and Assisted Living Facilities
• Global Dialysis Clinics
• Independent Laboratory Providers\
• COVID-19 Impact on Independent Laboratory Testing Markets, $millions

A Resource for IVD Manufacturers as Well as Laboratory Businesses

Many of Kalorama’s IVD manufacturer customers have found this annual review of the clinical labs market essential. Clinical laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Clinical laboratories are an essential part of the health industry.

In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. In oncology indications, clinical laboratory services are involved in 100% of patient care plans. Hospital and independent laboratories were the two listed types of laboratories for several years with hospitals accounting for approximately 90% of laboratory facilities.

Today, there is a shift in healthcare utilization primarily due to reducing healthcare spending, which makes the laboratory an even more valuable part of the treatment plan. In efforts to reduce health-related costs, hospitals have been striving to reduce length of stays. Although stays in U.S. hospitals were thought to have declined to about 4.3 days on average there has been some indication of an increase among some demographics in recent years. In recent years, the average length of hospital stay has been estimated at around 4.7 days. To continue to try and keep stays at a minimum and ultimately reduce cost, monitoring technologies, diagnostic imaging and laboratory measures and disease/treatment monitoring through diagnostic laboratory practices are primary ways physicians and administrators are continuing to meet optimal healthcare outcomes while also reduce costs.

Knowing the Clinical Lab Market, with the Aid of an Independent Resource, is Essential to Knowing the IVD Business

Global markets are also feeling pressures to reduce health spending. The length of stay on a global level is estimated at 6.6 days on average with Russia and Japan among the higher days of hospitalization. We can expect to see a consolidation in the number of clinical laboratories, particularly in the independent and community sectors, as these trends continue to influence the industry and add pressure to smaller clinical laboratories in an effort to reduce costs and still provide adequate healthcare.